The Quality Digest

March 2023 Edition

March 2, 2023

Clinical News

Safety and Patient Experience with At-Home Infusion of Ocrelizumab for Multiple Sclerosis

Amerita Specialty Infusion Services’ clinical leaders Lou Anne Epperson and Ashley Banks were among the authors on this recent study of safety and patient satisfaction with at-home infusion of ocrelizumab for MS, published in the Annals of Clinical and Translational Neurology.

Read More

Clinical Advisory: CDC Advises to Stop Use of EzriCare Artificial Tears Lubricant Eye Drops

The CDC urges halting use of EzriCare Artificial Tears Lubricant Eye Drops pending investigation into multi-state infection outbreaks causing permanent vision loss, hospitalization, and one death.

Read More

Clinical Alert: Omicron Subvariants Predominance Leads to EVUSHELD Halt

The FDA has updated the EUA for EVUSHELD and rescinded the authorization for use as pre-exposure prophylaxis of COVID-19 in every US region as it is not expected to neutralize numerous Omicron subvariants. There are currently no COVID-19 monoclonal antibodies authorized for any use.

Read More

JAYPIRCA™ and ORSERDU™ Now Available from Onco360

JAYPIRCA™ (pirtobrutinib) and ORSERDU™ (elacestrant) are now available from Onco360 for the treatment of relapsed or refractory mantle cell lymphoma and for some types of ER-positive metastatic breast cancer, respectively.

Read More on JAYPIRCA
Read More on ORSERDU

Monthly Minute: Tapering Medications

Check out this month’s “Monthly Minute,” developed by our Consultant Pharmacists, on pharmacy-related topics important to resident care.

Read More

Upcoming Events

All webinar times are 1:00pm ET / 12:00pm CT

Tuesday, March 7: Insulin Management

Tuesday, March 14: Talking Shop: Improving CNA-Nurse Communications in Long-Term Care

Tuesday, March 28: Drug Pricing Reform in Motion: What You Need to Know Now

Tuesday, April 11: MDS 1.18.11 Data Set Changes for Operational, Clinical, Financial, and MDS Managers


CMS plans to increase psychotropic drug oversight to include targeted audits. Listen to our latest “Spoonful of Sugar” podcast as hosts TJ Griffin and John O’Connor discuss the importance of implementing a psychotropic stewardship program to prevent headaches, problems, and costs down the line – and get a leg up if CMS decides to mandate such an initiative.

Listen Now